Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma
In Vivo · 2023
DOI: 10.21873/invivo.13205 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift In Vivo, 2023. Verfasst von Moriyasu Yamauchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head & Neck Surgery, Saga University Faculty of Medicine, Saga, Japan yamamori@cc.saga-u.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology - Head & Neck Surgery, Saga University Faculty of Medicine, Saga, Japan yamamori@cc.saga-u.ac.jp.
- Department of Otolaryngology - Head & Neck Surgery, Saga University Faculty of Medicine, Saga, Japan.
ORCID-Profile: Moriyasu Yamauchi
Zitieren
APA
Yamauchi, M., Minesaki, A., Ishida, T., Sato, Y., Okamura, S., Shuto, H., Tanaka, N., Hatayama, E., Shibamiya, N., & Kuratomi, Y. (2023). Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma. In Vivo. https://doi.org/10.21873/invivo.13205
Vancouver
Yamauchi M, Minesaki A, Ishida T, Sato Y, Okamura S, Shuto H, et al. Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma. In Vivo. 2023. doi:10.21873/invivo.13205
BibTeX
@article{Yamauchi2023,
author = {Yamauchi, Moriyasu and Minesaki, Akimichi and Ishida, Tomoya and Sato, Yuki and Okamura, Seiji and Shuto, Hiroyuki and Tanaka, Nariyuki and Hatayama, Eriko and Shibamiya, Natsuko and Kuratomi, Yuichiro},
title = {Induction Chemotherapy With 5-Fluorouracil, Cisplatin, and Cetuximab in Advanced Head and Neck Squamous Cell Carcinoma},
journal = {In Vivo},
year = {2023},
doi = {10.21873/invivo.13205}
}
EUVIMED